Cite
HARVARD Citation
Chen, X. et al. (2022). Pharmacokinetics of capmatinib in participants with hepatic impairment: A phase 1, open‐label, single‐dose, parallel‐group study. British journal of clinical pharmacology. 88 (1), pp. 91-102. [Online].